Literature DB >> 10998448

Progressive osseous heteroplasia: an uncommon cause of ossification of soft tissues.

C Stoll1, M R Javier, J P Bellocq.   

Abstract

Whereas the deposition of calcium within soft tissues is not infrequent, the development of highly structured, mineralized tissue histologically identifiable as true bone is uncommon and can cause a variety of clinical features. This article reports the clinical and radiological features in a patient with progressive osseous heteroplasia (POH), a recently identified disorder characterized by heterotopic ossification. The patient, a female, was 20 years of age at presentation. In addition to abnormal ossifications, she had short metacarpals at the fourth and fifth rays and short metatarsals at the second rays. Her parents were unaffected. Until the results of Rosenfeld and Kaplan in 1995 reporting POH in two boys, typical features had only been reported in females (n=8). POH is usually sporadic; however, familial associations and atypical phenotypes have been reported.

Entities:  

Mesh:

Year:  2000        PMID: 10998448     DOI: 10.1016/s0003-3995(00)00020-4

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  3 in total

1.  Progressive osseous heteroplasia: a case report and literature review.

Authors:  Keyun Zhang; Hairong Tang; Renming Zhang; Yongchao Wang; Qin Su; Xin Lin; Qiang Tian; Sheng Cao; Meichun Fu; Jian Zhu; Xiaoqing Shen; Feng Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Chronic ulcers, calcification and calcified fibrous tumours: phenotypic manifestations of a congenital disorder of heterotopic ossification.

Authors:  Susanne Kupitz; Stuart Enoch; Keith G Harding
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

3.  Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.

Authors:  N S Adegbite; M Xu; F S Kaplan; E M Shore; R J Pignolo
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.